GraphTX

Graph Therapeutics

This company develops artificial intelligence technology to create targeted therapies and biomarkers for patients with immune-mediated diseases.

Interlinetx

This company develops a precision medicine platform to map protein communities and discover small molecule drugs for patients with inflammatory diseases and cancer.

Immunai

Immunai develops an immune system mapping platform for biopharmaceutical companies to discover and optimise drug targets and clinical trials.

Micrographia Bio

This company develops AI-driven microscopy and spatial proteomics platforms to help drug developers and researchers visualise molecular interactions and identify therapeutic targets.

UbiquiTx

This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.

GC Therapeutics

This deep-tech company develops a cell programming platform to produce off-the-shelf medicines for patients with gastrointestinal, neurological and immunological diseases.

Spectacell

This company develops a label-free single-cell analysis platform for pharmaceutical and biotechnology organisations to measure the performance of immune therapies.

Epana

The company develops precision immune cell therapies and diagnostic atlases using genomics and artificial intelligence for patients with autoimmune diseases.